Speaker: Dr Cheah Soon Keat

Uncovering the Uncommon: Efficacy of Afatinib in Uncommon and Compound Mutations

Watch Dr Cheah Soon Keat as he discusses on the latest treatment strategy of treating uncommon EGFR mutation positive NSCLC patients based on evidence and clinical experience.